KeyCorp Upgrades Rapid Micro Biosystems (NASDAQ:RPID) to “Strong-Buy”

Rapid Micro Biosystems (NASDAQ:RPID) was upgraded by equities researchers at KeyCorp to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports.

Rapid Micro Biosystems Price Performance

RPID opened at $3.26 on Tuesday. Rapid Micro Biosystems has a fifty-two week low of $0.58 and a fifty-two week high of $3.30. The company has a market cap of $140.28 million, a price-to-earnings ratio of -2.91 and a beta of 1.26. The firm has a 50 day simple moving average of $1.40 and a 200 day simple moving average of $1.09.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.